for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Kelyniam Global Inc

KLYG.PK

Latest Trade

0.06USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

0.04

 - 

0.30

As of on the Over The Counter ∙ Minimum 15 minute delay

Pricing

Previous Close
0.06
Open
--
Volume
--
3M AVG Volume
0.26
Today's High
--
Today's Low
--
52 Week High
0.30
52 Week Low
0.04
Shares Out (MIL)
18.54
Market Cap (MIL)
0.96
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Kelyniam Global acquires MED-ALLY

Kelyniam Global Inc Reports Settlement of Lawsuit

Kelyniam Global Inc Receives 501k Approval For Custom Craniofacial Implants

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Kelyniam Global Inc

Kelyniam Global, Inc. is a medical device manufacturing company. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient's computed tomography (CT) scan data, the Company's 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its K-Plans include ke24, ke72 and kp5day. The Company's emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours. The ke72 plan provides the implants in approximately 72 hours. Its kp5day is a physical implant verification service.

Industry

Medical Equipment & Supplies

Contact Info

97 River Rd

COLLINSVILLE, CT

06019-3246

United States

+1.800.2808192

http://www.kelyniam.com/

Executive Leadership

Ross Bjella

Chairman of the Board, Chief Executive Officer

Terrance Kurtenbach

Chief Financial Officer

Christopher Breault

Chief Operating Officer

Mark Chenoweth

Vice President - Sales and Marketing

Mark Smith

Vice President - Sales and Business Development

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
1.86
Price To Book (MRQ)
3.36
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
165.42
LT Debt To Equity (MRQ)
101.44
Return on Investment (TTM)
-41.79
Return on Equity (TTM)
-33.57

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up